SUMMARY The objective of this study was to examine total exchangeable sodium, plasma-blood volume, and the status of the renin-angiotensln system in hypertensive diabetic patients with established nephropathy. We also evaluated hypertensive patients with diabetes who were free of clinically apparent nephropathy or other diabetic complications. Total exchangeable sodium (by M Na dilution) was expressed as percentage predicted. Subjects were studied as inpatients receiving unrestricted sodium intake and in stable metabolic control. Total exchangeable sodium was 100 ± 2% in controls (n = 42), higher (p < 0.01) at 108 ± 2% in normotensive patients with diabetes (n = 30), and higher still (p < 0.005) in hypertensive patients with diabetic nephropathy (n = 16) 118 ± 4% (p < 0.05 vs normotensive diabetics). The value correlated with blood pressure only in diabetics with nephropathy (r = 0.61, p < 0.01). Plasma renin activity, and blood and plasma volumes were similar in nephropathic diabetics and controls. Hypertensive patients with maturity-onset (type II) diabetes free of nephropathy (n = 18) were compared with nondiabetic controls (n = 16) and normotensive patients with type II diabetes (n = 18) of similar age. Total exchangeable sodium in the controls was 100 ± 3%, higher (p < 0.01) in normotensive diabetics at 109 ± 2%, but not significantly elevated in hypertensive diabetics at 106 ± 2%. Again, blood and plasma volumes did not differ among the groups. Plasma renin activity was suppressed (p < 0.01) to a comparable degree in both normotensive and hypertensive patients with type II diabetes. Both sodium retention and the renin-angiotensin system may contribute to nephropathic diabetic hypertension. In nonnephropathic hypertension, sodium retention is not prominent and plasma renin activity is suppressed. 2 Hypertension usually accompanies established diabetic nephropathy in patients with both type I and type II diabetes 3 ' * and is likely to contribute to the acceleration of diabetic renal disease.
H YPERTENSION in diabetes is a major contributor to both atherosclerotic 1 and microvascular complications.
2 Hypertension usually accompanies established diabetic nephropathy in patients with both type I and type II diabetes 3 ' * and is likely to contribute to the acceleration of diabetic renal disease. 56 It is also frequently observed in patients with type II diabetes who are free of proteinuria and is a major predictor of mortality in these persons. 7 The nature of hypertension in diabetics who are free of nephropathy is unclear.
The objective of this study was to examine total exchangeable sodium (NaE), plasma-blood volume, and status of the renin-angiotensin system in hyperten-sive diabetic patients with and without nephropathy. Previous studies demonstrated elevated NaE in diabetics with microvascular complications and in those with hypertension. 89 Patients with frank nephropathy have not previously been studied in this regard, nor have hypertensive subjects with type II diabetes who are free of microangiographic complications been well characterized.
Reports conflict on the status of the renin-angiotensin system in diabetic patients with nephropathy. Earlier work suggested that plasma renin activity (PRA) was low, 10 while more recent indications are that PRA" and plasma angiotensin II may not be suppressed in diabetics with nephropathy. 12 In hypertensive diabetic patients free of overt nephropathy, normal 8 and low 13 PRA have been noted. The reasons for these discrepant findings are not clear. One reason may be that patients with hypertension of mixed etiology may have been included in previous studies. We attempted to separate patients into two groups: 1) those with established proteinuria and hypertension and 2) those with hypertension and no clinically apparent proteinuria or diabetic complications. 
Patients and Methods
In the first study we examined three groups of patients: nondiabetic controls (n = 42), normotensive diabetics free of clinically apparent diabetic complications (« = 30, 10 with type I and 20 with type II diabetes), and hypertensive patients with diabetes with established nephropathy (n = 16). Established diabetic nephropathy was defined as 24-hour urinary protein excretion greater than 0.5 g in the absence of cardiac failure and urinary tract infection.
14 Hypertension was defined as blood pressure consistently higher than 140/90 mm Hg in the outpatient department. Diabetes was classified by the criteria of the National Diabetes Group. 15 Nondiabetic controls were healthy persons, patients admitted to hospital for minor surgical procedures, and subjects recovered from medical illnesses not involving renal, cardiovascular, and/or hepatic systems. All were ambulatory, unrestricted with respect to sodium and caloric intake, and were studied as inpatients.
Normotensive diabetics were free of clinically apparent diabetic complications including cardiovascular autonomic neuropathy (tested by cardiac beat-to-beat variation with maximum respiration). All were free of proteinuria as assessed by a standard commercial dipstick method. Those with diabetic nephropathy all had several diabetic microvascular complications including retinopathy and evidence of autonomic and peripheral neuropathy. Subjects were excluded if they had clinical evidence of cardiac failure or ischemic electrocardiographic abnormalities or peripheral vascular disease. Hypertensive patients with type II diabetes (n = 18) tended to be older than those with diabetic nephropathy and were therefore compared with a subgroup of normotensive persons with type II diabetes (n = 18) and nondiabetic controls of similar age (n = 16). These diabetic patients were also free of cardiovascular autonomic neuropathy and proteinuria ( < 0.3 g/24 hr).
Diabetic patients were admitted to hospital and were studied after diabetic control was stabilized, as assessed by a five-or six-sample 24-hour blood glucose profile and by glycosylated hemoglobin (HbA,) measurements. Blood pressure, blood volume, and PRA were measured in the supine position after overnight rest.
Total exchangeable sodium was measured usinĝ Na 16 and results were expressed as percentage predicted by leanness index (heightVweight in mVkg) to take account of differences in body build. 17 This relationship was defined in the control population by the following equation: NaE predicted (mmol/kg) = 17.43 + 349 X leanness index (r = 0.69, n = 42, p < 0.001), a relationship similar to previous reports. 18 Values for NaE in the control population were similar to those in published reports and indicated that the control population was sodium replete." Plasma-blood volume was measured by a multiple-sampling technique using l23 I-labeled human serum albumin 20 in 21 control subjects, 24 normotensive patients with diabetes, 12 with nephropathy, and 15 with nonnephropathic hypertension. The PRA was measured by radioimmunoassay. The sodium-renin product was expressed in arbitrary units and calculated as NaE (percentage predicted) x log PRA (pg/ml/hr angiotensin I). 21 Statistical calculations employed analysis of variance (ANOVA), Newman-Keuls multiple range tests, linear regression, and the Pearson correlation coefficient; results are expressed as mean ± SEM.
Results

Hypertensive Patients with Nephropathy
Patients with diabetic nephropathy were similar to control subjects and normotensive diabetics in age, leanness index, and body surface area (Table 1, Figure  1 ). Metabolic control in the two diabetic groups did not differ. Plasma sodium concentration was similar in controls and normotensive diabetic persons but was on average 3 mmol/L lower in those with diabetic nephropathy (p < 0.05). Plasma potassium concentration did not differ among the groups. Plasma albumin concentration was significantly lower in nephropathic patients compared to the others. Urinary 24-hour sodium excretion did not differ significantly among the groups. Urinary protein excretion was higher in normotensive diabetic patients compared to controls (p < 0.01), while protein excretion was clearly higher in all patients with diabetic nephropathy. Creatinine clearance was similar in controls and normotensive diabetics but was significantly lower in nephropathic patients compared to the other two groups.
The NaE was 100 ± 2% in controls, higher (p < 0.01) in normotensive subjects with diabetes 108 ± 1%, and was higher still (p < 0.005; 118 ± 4%) in hypertensive persons with diabetic nephropathy (p < 0.05 vs normotensive diabetics). The NaE did not differ significantly between nephropathic patients with type I or II diabetes. Neither blood volume nor plasma volume differed significantly among the three groups. The PRA was lower (p < 0.05) in normotensive diabetics as a whole compared to controls, while PRA in those with diabetic nephropathy were similar to controls. The sodium-renin product was similar in normotensive diabetics compared to controls, while in hypertensive nephropathic diabetics it was higher than that in both normotensive diabetics (p < 0.01) and controls {p < 0.01).
Blood pressure did not correlate significantly with NaE in controls or normotensive diabetics but did in nephropathic patients (r = 0.61, p < 0.01). There were no significant relationships between urinary sodium excretion and NaE, PRA, or blood pressure in any of the groups. In those with diabetic nephropathy, mean arterial pressure was positively related to the log l0 (as the distribution of urinary protein excretion tended to be skewed) of urinary protein excretion (r = 0.66, p < 0.01) and inversely related to creatinine clearance (r = -0.64, p < 0.01).
Patients with Nonnephropathic Hypertensive Diabetes
Mean age, leanness index, body surface area, 24-hour urinary sodium excretion, creatinine clearance, and plasma sodium and plasma potassium concentrations did not differ significantly among controls, normotensive, and hypertensive diabetics (Table 2, Figure 2) . Mean blood glucose and HbA, were similar in the diabetic groups. Urinary albumin excretion was significantly higher in both the normotensive and hypertensive patients compared to controls but did not reach clinically detectable levels in either group. The NaE was 99.9 ± 2.5% predicted in controls, higher in normotensive diabetics (108.9 ± 2.0%, p < 0.01), and in hypertensives (105.5 ± 2.4%) was between that of controls and normotensive diabetics without being elevated to a statistically significant degree. Plasma and blood volume did not differ significantly among the groups, although it was evident that hypertensive patients did not have a higher intravascular volume than normotensive patients. The PRA was clearly lower (p < 0.01) in both normotensive and hypertensive patients to a similar degree.
There were no significant correlations between blood pressure and NaE, intravascular volume, PRA, creatinine clearance, or urinary sodium or albumin excretion in any group. Urinary sodium excretion was not related to any variable, including NaE and PRA.
Discussion
We found elevated NaE in normotensive diabetic patients who were free of complications, higher levels in hypertensive diabetic patients with nephropathy, and a trend toward elevated levels in diabetic hypertensive patients free of nephropathy. Elevated NaE was previously demonstrated in normotensive diabetics with microangiopathic complications, 89 and as observed here, may occur before the development of clinically apparent microangiopathy in both types I and II diabetes. The cause of this sodium retention is not clear, but it may be an early renal disturbance combined with altered distribution of extracellular fluid volume. 22 In diabetic persons with nephropathic hypertension, NaE was further elevated and correlated with blood pressure, as is the case in other forms of secondary renal (parenchymal) hypertension, although the magnitude of the sodium retention is greater in persons with diabetes. 23 Although renal sodium handling must alter in diabetic nephropathy, there are additional possible causes of sodium retention in these patients when accompanying diabetic complications occur, such as decreased plasma proteins (as was the case in a few of our patients), increased capillary permeability to albumin, 20 and peripheral and autonomic neuropathy. 24 In contrast to nephropathic patients, NaE was not significantly elevated in those with nonnephropathic hypertension and did not correlate with blood pressure; however, NaE was on average 6% higher in this group and a trend toward sodium retention was apparent. These observations differ slightly from those of previous reports 8 ' M in which sodium retention was clearly shown in hypertensive nonazotemic diabetic patients. In the latter studies, 24-hour urinary protein measurements were not available and thus some subjects with nonazotemic diabetic nephropathy may have been included, which could have contributed to the greater sodium retention. Such patients were specifically excluded in the current study. In nondiabetic essential hypertension, sodium retention is not a feature and there is no significant relationship between arterial pressure and NaE in younger patients. 
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Blood volume was not clearly elevated in any group compared to controls. This may seem surprising in those with nephropathic hypertension; however, studies on blood volume in nondiabetics with hypertension and renal impairment have also not clearly demonstrated elevated blood volume, 23 a finding that may reflect whole-body autoregulation of blood flow. 28 It was suggested that poor diabetic control with hyperglycemic extracellular fluid volume expansion may lead to blood volume expansion and aggravation of hypertension 29 ; however, blood volume is not increased by nonketotic poor diabetic control. 30 In patients with nonnephropathic hypertension, plasma and blood volume tended to be lower than their normotensive counterparts, a trend well documented in nondiabetic essential hypertension. 31 In summary, expanded intravascular volume in the steady state was not a feature of any of the diabetic groups studied, which agrees with a previous report. 8 Data on the renin-angiotensin system in diabetics with nephropathy are conflicting. In the present study, PRA levels in hypertensive patients with diabetic nephropathy were similar to those of controls, consistent with our earlier study of plasma angiotensin II levels. 12 Christlieb et al. 10 observed a diminished PRA response to sodium restriction in nephropathic subjects. These findings could be reconciled with our observations if we assume that patients in the former report were in positive sodium balance and thus might be expected to mount a lower renin response compared to healthy persons when subjected to sodium restriction. The renin-angiotensin system behaves inappropriately in some forms of nephropathic hypertension, 18 and it has been suggested that an elevated sodiumrenin product may indicate that inappropriate renin release in conjunction with sodium retention is contributing to nephropathic hypertension. 23 This may have been the case in at least some of the patients in this study. In addition, sodium retention may potentiate the pressor responsiveness of both circulating angiotensin II and norepinephrine. 22 ' 23 In nonnephropathic hypertensive diabetic patients, PRA was markedly suppressed and thus it is unlikely that the renin-angiotensin system played a leading role in maintaining hypertension. We previously compared these hypertensive patients with nondiabetic patients with essential hypertension and found PRA to be lower in those with diabetes. 27 An age-related decline in PRA is commonly observed in both nondiabetic and diabetic persons. 8 - 22 However, the age-adjusted suppressed PRA in those with type II diabetes is not well explained and may represent a response to sodium retention, as in normotensive diabetics, or increased vascular reactivity to pressor stimuli. 22 In conclusion, sodium retention was a prominent feature of nephropathic hypertension, and the reninangiotensin system was not suppressed in many patients. By contrast, in nonnephropathic hypertension, sodium retention was less prominent and PRA was markedly suppressed.
